Cancer nanotheranostics: next-generation early detection and treatment prioritization for cancers using phytonanotechnology

Help | Contact us

Mufamadi, M.S., John, M.J., Ngoepe, M.P. & Sekhejane, P.R. (2021) Cancer nanotheranostics: next-generation early detection and treatment prioritization for cancers using phytonanotechnology. In: Glover, R.L.K., Nyanganyura, D., Mufamadi, M.S. & Mulaudzi, R.B. (eds).Green synthesis in nanomedicine and human health. Boca Raton, Florida: CRC Press. 17-29. http://hdl.handle.net/20.500.11910/15823

http://hdl.handle.net/20.500.11910/15823
 
Abstract:
Cancer is basically a group of diseases involving genetic changes leading to uncontrolled cell proliferation in cancerous cells and tumour formation. The numbers of cancer cases are on the rise in Sub-Saharan African (SSA) due to the increase in the adoption of westernized lifestyle, changes in diet and reduction in physical activity among the African population (Chokunonga et al., 2013; Azubuike et al., 2018). The most common cancers in SSA countries are the breast and cervical cancers in women, and prostate cancer in men, as well as Kaposi's sarcoma and non-Hodgkin lymphomas as a result of the HIV/AIDS epidemic. Most cancer cases are diagnosed at an advanced stage in Africa, which contributes to poor prognoses (Stefan, 2015; Rebbeck, 2020).
Reference:
If you would like to obtain a copy of this Research Output, please contact the Research Outputs curators at researchoutputs@hsrc.ac.za

Attribution-NonCommercial
CC BY-NC

This license lets others remix, adapt, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.
 
25 Feb 2021
 
SUB-SAHARAN AFRICA
TREATMENT
CANCER
 
Show full item record
 
 

This item appears in the following Collection(s)